HCV entry receptors as potential targets for siRNA-based inhibition of HCV

BACKGROUND: Hepatitis C virus (HCV) is a major health concern with almost 3% of the world's population (350 million individuals) and 10% of the Pakistani population chronically infected with this viral pathogen. The current therapy of interferon-α and ribavirin against HCV has limited efficienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahan, Shah, Samreen, Baila, Khaliq, Saba, Ijaz, Bushra, Khan, Mahwish, Siddique, Muhammad Hassan, Ahmad, Waqar, Hassan, Sajida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179693/
https://www.ncbi.nlm.nih.gov/pubmed/21896165
http://dx.doi.org/10.1186/1479-0556-9-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179693/
https://www.ncbi.nlm.nih.gov/pubmed/21896165
http://dx.doi.org/10.1186/1479-0556-9-15

Ejemplares similares